Cryptobiotix is a preclinical CRO providing insights into the gastrointestinal tract and gut microbiome. The validated, ex vivo SIFR® technology combines unmatched throughput and predictivity for clinical outcomes. We offer research services to customers in the area of functional foods and therapeutic products, across foodtech, biotech and pharma.
From early R&D screening to in-depth characterisation, we address your specific research questions and provide you with the answers to accelerate and de-risk your product development.
Company Details
- Employees
- 18
- Founded
- -
- Address
- Technologiepark Zwijnaarde, 82,belgium
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.cryptobiotix.eu
- Keywords
- R&D, gut, microbiome, digestion, fermentation, in silico, in vitro, scientific writing, SIFR, D-SIFR, Product development, screening, ex vivo, CRO, preclinical.
- HQ
- Ghent, Flanders
Cryptobiotix Questions
Cryptobiotix's website is http://www.cryptobiotix.eu
Cryptobiotix's LinkedIn profile is https://be.linkedin.com/company/cryptobiotix
Cryptobiotix has
18 employees.
View email and phone details for 18
employees at Cryptobiotix.
Cryptobiotix's industry is
Biotechnology Research
Cryptobiotix's top competitors are
Confo Therapeutics,
Isomerase,
Aelius Biotech,
Syndex Bio,
Mrm Health,
Agomab,
Ablynx,
Constructive Bio,
Prodigest,
Flamingo Therapeutics.
Cryptobiotix's categories are Biotechnology Research
Cryptobiotix's founding year is 2021
